The pathogenicity and future treatment strategies of <i>Candida albicans</i>. [PDF]
Wu J +5 more
europepmc +1 more source
The gut-liver-immune axis: structural basis, cellular architecture, molecular mediators, and disease-specific manifestations. [PDF]
Yoon SJ, Eom JA, Suk KT.
europepmc +1 more source
The role and possible mechanism of intestinal fungi in the progression of chronic liver diseases. [PDF]
Hu Y, Yang Y, Wang S, Chu H.
europepmc +1 more source
Fungal infection drives metabolic reprogramming in epithelial cells via aerobic glycolysis and an alternative TCA cycle shunt. [PDF]
Pellon A +22 more
europepmc +1 more source
Critical parameters of fungal pathogenicity at the epithelial interphase. [PDF]
Möslinger A +3 more
europepmc +1 more source
Epidemiology, Diagnostics and Therapy of Vulvovaginal Fungal Infections. [PDF]
Frej-Mądrzak M +4 more
europepmc +1 more source
Candida albicans hyphae modulate Staphylococcus aureus cell-free supernatant during dual biofilm growth to drive molecular signatures of oral dysplasia. [PDF]
Marin-Dett FH +6 more
europepmc +1 more source
Yeasts in the gastrointestinal tract. [PDF]
Mueller KD, Lee SC.
europepmc +1 more source
Molecular mechanisms, pathogenesis and therapeutic advances of <i>Candida albicans</i> in oral candidiasis. [PDF]
Sahu BK +5 more
europepmc +1 more source
Investigating the human-animal interface: Clinical and molecular features of oral <i>Candida spp.</i> in cat owners. [PDF]
Ali MA, Al-Ezzy AIA.
europepmc +1 more source

